Dutasteride Side Effects: What Men Need to Know Before Starting Avodart

Dutasteride causes sexual side effects in a minority of men, including decreased libido, erectile dysfunction and ejaculatory dysfunction. These are thought to result from the deep DHT reduction impairing androgen-dependent sexual function. Most resolve on discontinuation, but because dutasteride has a long half-life (about five weeks), resolution can take months after stopping — much longer than finasteride, whose effect wears off over days to weeks.

Sexual side effects occur at similar absolute rates with dutasteride and finasteride in clinical trials. The key differences: dutasteride achieves deeper DHT suppression (90–95% vs. 70%), which may explain why some men report more pronounced libido effects. Dutasteride's 5-week half-life means any side effects that develop persist significantly longer after discontinuation than finasteride. Men concerned about sexual side effects should discuss this washout difference with their urologist.

Yes — dutasteride reduces PSA by approximately 50% after 6 months of continuous use. This is clinically important: a man on dutasteride with a PSA of 2.0 ng/mL has a true equivalent PSA of ~4.0 ng/mL. Urologists must double the PSA reading for cancer screening interpretation in men on dutasteride. If PSA rises or fails to fall >50% on dutasteride, biopsy should be considered — PSA increase on dutasteride is an abnormal finding.

The main precaution concerns women of childbearing potential and pregnant women specifically, since dutasteride is absorbed through skin and can affect a male fetus's development — broken or leaking capsules should never be handled by a woman who is or might be pregnant, and intact capsules should be stored safely. There's no similar concern with normal, incidental contact like sharing a household, and men taking dutasteride don't need to take special precautions around other family members beyond this specific pregnancy-related warning.

Dutasteride monotherapy is appropriate and effective for many men, particularly those with moderate symptoms and smaller-to-moderate prostate volumes, and it's not automatically necessary to combine it with an alpha-blocker from the start. The CombAT study found that combination therapy outperformed either monotherapy in men with moderate-to-severe symptoms and enlarged prostates, but with significantly more drug-related adverse events [1], so the decision to combine or use dutasteride alone should reflect individual symptom severity and prostate size rather than assuming combination therapy is always the default starting approach.

Meaningful prostate volume reduction and symptom improvement typically take months of consistent use to become clearly apparent, considerably slower than an alpha-blocker's response, since dutasteride works by gradually shrinking glandular tissue rather than acutely relaxing smooth muscle. This slower onset is exactly why dutasteride is often combined with a faster-acting alpha-blocker for men with significant symptoms who need relief sooner than dutasteride alone would provide, then continued long-term for its more durable volume-reduction benefit.

Yes — men taking dutasteride are generally deferred from donating blood for a period after their last dose, due to the risk of exposing a pregnant recipient to the medication through transfusion, similar to the precaution around handling broken capsules. The specific deferral period varies by blood donation organization and region, so checking directly with the local blood donation center is the reliable way to confirm current eligibility requirements while on or after stopping dutasteride.

Yes — generic dutasteride is bioequivalent to Avodart and works identically in terms of mechanism and expected clinical effect, with generic pricing being substantially more affordable now that patent protection has expired. There's no established clinical reason to prefer brand-name Avodart specifically, and generic is the standard, cost-effective choice for essentially all men prescribed dutasteride today.

Yes — dutasteride is used off-label for androgenetic alopecia, and some research suggests it may be more effective than finasteride for hair regrowth given its more complete DHT suppression, though it also isn't FDA-approved specifically for this indication in most regions and carries the same longer-washout consideration discussed above. Men considering dutasteride specifically for hair loss should weigh this stronger potential efficacy against the longer side-effect persistence window compared to finasteride, ideally in conversation with a dermatologist or physician experienced with both options.

There's no strong established evidence that dutasteride directly causes weight gain or meaningfully alters metabolism — weight changes reported anecdotally by some users are more plausibly explained by other factors (aging, activity level, diet) than a direct pharmacological effect of DHT suppression on metabolism. If unexplained weight gain occurs while on dutasteride, it's reasonable to investigate other more established causes (thyroid function, lifestyle changes, other medications) rather than assuming dutasteride itself is the direct culprit.

There's no strict requirement for a specific time of day, though taking it consistently at the same time each day, with or without food per the specific product's guidance, helps maintain steady drug levels and makes it easier to remember as part of a daily routine. Consistency in timing matters more than the specific hour chosen, similar to most once-daily chronic medications.